Acute Lymphoblastic Leukemia | Topics

 
TBI Plus Etoposide Prior to HSCT Leads to Improved OS, Lower Relapse Risk in High-Risk Pediatric ALL
January 19, 2021

Based on recent study results, investigators recommended TBI plus etoposide for patients older than 4 years of age with high-risk ALL undergoing allogeneic hematopoietic stem cell transplantation.

Patients with Ph- B-cell ALL May Benefit From Addition of Blinatumomab to Chemotherapy Combo
January 13, 2021

The addition of the monoclonal antibody blinatumomab to hyper-CVAD could represent a potential option for extending remission times in patients with Philadelphia chromosome–negative B-cell acute lymphoblastic leukemia.

Nicholas J. Short, MD, on the Future of ALL and Possibilities for Transplant in These Patients
January 06, 2021

Short expanded on the future of acute lymphoblastic leukemia and transplantation necessity at the 2020 ASH Annual Meeting & Exposition.